Levofloxacino Farmalider (Levofloxacin)

Levofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By blocking these targets, the drug prevents bacterial DNA synthesis and transcription, leading to rapid bacterial cell death. This mechanism provides bactericidal activity against a wide range of Gram‑negative and Gram‑positive organisms.

The specific dose and duration are determined by the prescribing clinician based on the type and severity of infection, patient age, renal function, and other clinical factors. Levofloxacin dosing is individualized, and the prescriber will select the appropriate regimen from the product’s labeling.

Safety data for levofloxacin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Levofloxacin and ciprofloxacin belong to the same class but differ in spectrum and pharmacokinetics. Levofloxacin offers enhanced activity against Gram‑positive organisms, including Streptococcus pneumoniae, while ciprofloxacin is more potent against certain Gram‑negative bacteria. Both share similar safety concerns, but levofloxacin’s once‑daily dosing can improve adherence for many infections.

Store the product at room temperature, preferably below 25 °C. Keep the tablets in their original packaging to protect them from moisture and light. Do not store in a refrigerator or freezer, and ensure the container is tightly closed to maintain stability.

Levofloxacino Farmalider is taken orally. Swallow the tablet whole with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal upset for some patients. Follow the prescriber’s instructions regarding timing and any necessary fluid intake.

Serious adverse events include tendon rupture (especially the Achilles tendon), QT interval prolongation leading to arrhythmias, severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, peripheral neuropathy, and hepatic injury. Patients should be educated to report any sudden joint pain, palpitations, rash, or persistent diarrhea promptly.

Levofloxacino Farmalider should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, patients receiving concomitant corticosteroids for prolonged periods, and individuals with certain cardiac conditions that predispose to QT prolongation. Clinicians must also consider renal impairment and adjust therapy accordingly.